VISTA-LIFE PHARMA
Absorbed by URGOOverview
Official details
Source: KBO- Status
- Absorbed by URGO merger by absorption, December 2025
- Activity
- “La société a pour objet:le développement,la production,la vente et la promotion de produits para-pharmaceutiques…” (deed in French)From the articles, 6 activitiesNo NACE code in the KBO yet
- Joint committee
- 207 White-collar workers in the chemical industry · annual accounts 2025
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Board and ownership
Board
- Briac Le LousChair
- Anne Martinet DurocherDaily manager
- Antoine BonDirector · since 07-01-2025
Shareholders
- URGO100%· score 67annual accounts 2025
Financial position
No score
Annual accounts 2025
- Turnover
- €5.0m
- Profit
- €1.2m
- ▲ 12.6%
- Equity
- €2.9m
- ▲ 73.8%
- Total assets
- €3.9m
- ▲ 79.9%
Equity +74%: absorbed
Key points
- Equity rose in 2025absorbed by URGO ▲ 73.8% View
Recent changes
- · Gazette deed Merger: absorbed by URGODissolution of the company · Dissolved without liquidation on 31-12-2025 · Books and records kept by the absorbing company
- · Gazette deed Merger proposal: to be absorbed by Urgo SA“La recherche, l'étude, l'exploitation, la fabrication, le commerce, la représentation, le conditionnement des…” (deed in French) · Urgo SA holds all the shares
- · Gazette deed Resignation: Gauthier Lauwers (daily management delegate)
Key facts about VISTA-LIFE PHARMA
- What is the company number of VISTA-LIFE PHARMA?
- The company number of VISTA-LIFE PHARMA is 0820.402.640. The VAT number is the same number with BE in front: BE 0820.402.640.
- What is the legal form of VISTA-LIFE PHARMA?
- Legal form of VISTA-LIFE PHARMA: SA.
- Is VISTA-LIFE PHARMA still active?
- No. VISTA-LIFE PHARMA is inactive in the KBO register.Company details
- How many employees did VISTA-LIFE PHARMA have?
- VISTA-LIFE PHARMA had an average of 0.5 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- Which joint committee does VISTA-LIFE PHARMA fall under?
- In its 2025 annual accounts, VISTA-LIFE PHARMA states joint committee 207 (White-collar workers in the chemical industry).
- What is the turnover of VISTA-LIFE PHARMA?
- The turnover of VISTA-LIFE PHARMA was €5.0m in financial year 2025, according to the filed annual accounts.
- Is VISTA-LIFE PHARMA profitable?
- In financial year 2025, VISTA-LIFE PHARMA made a profit of €1.2m.
- Where can I find the annual accounts of VISTA-LIFE PHARMA?
- VISTA-LIFE PHARMA filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.